Centre rushes experts to look into Madhya Pradesh deaths linked to cough syrup

A National Centre for Disease Control team was sent to investigate the death of six children due to kidney-related complications allegedly after cough syrup consumption

Published on: Oct 1, 2025, 16:16:40 IST

By Rhythma Kaul

Prefer HTon Google

Share via

Copy link

Union health and family welfare ministry has sent a team of experts from the National Centre for Disease Control (NCDC) to Madhya Pradesh’s Chhindwara district to investigate the death of six children due to kidney-related complications between September 4 and September 26 allegedly after having contaminated cough syrup, people familiar with the matter said. One death was reported from Rajasthan’s Sikar.

The team was collecting samples for testing. The State Drugs Authority has also taken samples to test them for contamination. “The NCDC team has been sent to rule out the possibility of any infectious disease. Different agencies are currently involved in testing samples such as water, entomological, drugs, etc,” said an official, requesting anonymity.

The official said the test reports are awaited. “All related results will be shared with the state authorities for further analysis and action.”

The Rajasthan Medical Services Corporation banned the sale and use of the syrup’s 19 batches. The state health department issued advisories to parents, doctors, and medical operators to be vigilant.

Chhindwara district magistrate Sheelendra Singh on Tuesday told ANI that the fatalities were reported from September 4, and no new cases have emerged. “We have taken extra precautions regarding issues related to viruses and bacteria. An RRD [Rapid Response and Diagnosis] team has arrived from Bhopal.”

Singh said experts have come to review the combination of medicines being used. “...teams are here to investigate vector-borne diseases as well. Officials from Delhi and Bhopal have arrived. The district administration is actively working on the matter.”

ABOUT THE AUTHOR
Rhythma Kaul
Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather major national developments and Karnataka Bandh LIVE.